Feature Channels: Autoimmune Diseases

Filters close
Released: 9-Dec-2021 7:00 AM EST
Drug made from pig intestine helps escape the “trap” of clot-causing immune response
Michigan Medicine - University of Michigan

Two complementary studies show that defibrotide can successfully suppress the formation and progression of neutrophil extracellular traps, or NETs, which are web-like networks of toxic proteins that play a role in forming blood clots and promoting inflammation in several disease, including COVID-19. Researchers say findings may set the stage for defibrotide clinical trials in potentially several diseases.

Released: 22-Nov-2021 3:40 PM EST
Rheumatoid arthritis finding may lead to new inflammation blockers
Mayo Clinic

Mayo Clinic researchers have linked the T cell dysfunction seen in rheumatoid arthritis with a metabolic deficiency in a new Nature Immunology publication.

Newswise: Suffering from psoriasis? Blame this trio of proteins
16-Nov-2021 6:15 PM EST
Suffering from psoriasis? Blame this trio of proteins
La Jolla Institute for Immunology

About 7.5 million Americans suffer from psoriasis, an autoimmune disease that shows up as patches of red, inflamed skin and painful, scaly rashes. Although there are effective treatments for psoriasis, not everyone responds to these therapies—and for many, the relief is temporary.

Released: 19-Nov-2021 12:55 PM EST
COVID-19 vaccine elicits weak antibody response in people taking immunosuppressant
Washington University in St. Louis

People taking TNF inhibitors, a kind of immunosuppressive drug used to treat rheumatoid arthritis and other autoimmune conditions, produced a weaker and shorter-lived antibody response after two doses of Pfizer's COVID-19 vaccine, according to a study from Washington University School of Medicine in St. Louis. A third vaccine dose drove antibody levels back up, indicating that this additional dose may provide protection as the virus's delta variant continues to spread.

Released: 18-Nov-2021 9:00 AM EST
$10 Million Gift Establishes New Colton Center for Autoimmunity at Penn Medicine
Perelman School of Medicine at the University of Pennsylvania

The Perelman School of Medicine at the University of Pennsylvania will continue to be on the leading edge of autoimmune research and care with the launch of the Colton Center for Autoimmunity at Penn. The new center unites research and patient care programs across Penn to drive advances in autoimmune diagnosis, prognosis, and treatment.

4-Nov-2021 2:30 PM EDT
An Inflammation to Remember
American Technion Society

A new discovery of a physiological mechanism of psychosomatic illnesses could open a new therapeutic avenue for treating chronic inflammatory conditions such as Crohn's disease, psoriasis, and other autoimmune conditions, by attenuating their memory trace in the brain.

7-Nov-2021 9:00 AM EST
Research Reveals Racial and Ethnic Disparities Persist in Pregnancy Outcomes of Patients with Lupus
Hospital for Special Surgery

While investigators have known that maternal and fetal outcomes of pregnancy among women with systemic lupus erythematosus (SLE) have improved over time, it is unknown whether the improved outcomes are shared equally among different racial and ethnic groups. Lupus has been shown to disproportionately affect minorities of childbearing age. A new study that includes researchers from Hospital for Special Surgery (HSS) presented today at the American College of Rheumatology (ACR) annual meeting shows that pregnancy outcomes in women with lupus have improved in all racial and ethnic groups over the past decade, but disparities still exist.

5-Nov-2021 5:00 PM EDT
HSS Study Identifies Risk Factors for “Long-Haul” COVID-19 in People with Rheumatic Diseases
Hospital for Special Surgery

A new study by researchers at Hospital for Special Surgery (HSS) in New York City demonstrates over half of patients with rheumatic diseases who contracted COVID-19 during the pandemic and completed a COVID-19 survey, experienced so-called “long-haul” COVID, or prolonged symptoms of the infection, including loss of taste or smell, muscle aches and difficulty concentrating, for one month or longer.

Released: 2-Nov-2021 2:25 PM EDT
Study Finds Systemic Autoimmune Disease Patients Fare Well After Transplants, Making Surgery a Viable Treatment Option for End-Stage Lung Disease
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that people with systemic autoimmune diseases do as well after lung or heart-lung transplants as those without any systemic causes of end-stage lung disease.

Released: 1-Nov-2021 4:55 PM EDT
Nearly One Third of Lupus Patients in One Study Had Low Responses to COVID-19 Vaccines
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that nearly 30% of patients with lupus in a multi-ethnic and multi-racial study had a low response to the new COVID-19 vaccines.

Released: 1-Nov-2021 4:50 PM EDT
Black People with Systemic Sclerosis May Have More Severe Disease, Worse Prognosis
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that Black people living with systemic sclerosis may have more severe disease and worse prognosis than patients in other racial or ethnic groups.

Released: 1-Nov-2021 3:55 PM EDT
Ultra-Low Dose Rituximab Controls Disease Activity for Most RA Patients in New Study
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows the majority of rheumatoid arthritis patients on an ultra-low dose of rituximab maintained low disease activity for up to 4 years, and rarely needed to switch to other biologic drugs.

Released: 1-Nov-2021 3:40 PM EDT
Hydroxychloroquine, Mainstay Lupus Treatment, Not Associated With Serious Cardiac Complication
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that hydroxychloroquine does not appear to be associated with QTc interval prolongation.

Released: 1-Nov-2021 3:30 PM EDT
Platelet Inhibitors May Reduce Digital Ulcers, a Common, Painful Systemic Sclerosis Complication
American College of Rheumatology (ACR)

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that use of platelet inhibitors could be associated with a reduction in the occurrence of digital ulcers in people with systemic sclerosis.

31-Oct-2021 10:00 AM EDT
NYU Langone Presentations at American College of Rheumatology Convergence 2021 to Address Vaccine Efficacy and High-risk Pregnancy
NYU Langone Health

NYU Langone rheumatologists are presenting their discoveries at the annual American College of Rheumatology conference, November 1 to November 9. The conference will be held virtually.

Released: 26-Oct-2021 11:20 AM EDT
Patients with rare scleroderma have deadlier organ damage, despite getting standard treatment
Michigan Medicine - University of Michigan

Patients with a rare form of scleroderma that causes more skin thickening have a greater chance of dying from related heart, lung and kidney problems, a new study found. This occurs despite the patient population taking drugs used to treat most people with scleroderma. Researchers say it is an opportunity for more targeted drug development.

Released: 25-Oct-2021 1:10 PM EDT
Evaluation of lupus arthritis using frequency domain optical imaging
NYU Tandon School of Engineering

Systemic lupus erythematosus (SLE), commonly referred to as simply “lupus”, is an autoimmune disorder where the body’s immune system attacks healthy tissue.

   
Newswise: Einstein-Developed Treatment Strategy May Lead to HIV Cure
21-Oct-2021 11:50 AM EDT
Einstein-Developed Treatment Strategy May Lead to HIV Cure
Albert Einstein College of Medicine

Armed with a novel strategy they developed for bolstering the body’s immune response, scientists at Albert Einstein College of Medicine have successfully suppressed HIV infections in mice—offering a path to a functional cure for HIV and other chronic viral infections. Their findings were published today in the Journal of Clinical Investigation.

Released: 18-Oct-2021 10:00 AM EDT
Renowned Clinician–Scientist Joins Division of Rheumatology at NYU Langone Health
NYU Langone Health

Dr. David Beck, nationally known for his work studying a novel inflammatory disorder called VEXAS, joins NYU Langone’s Division of Rheumatology.

Released: 6-Oct-2021 9:00 AM EDT
Cell ‘Fingerprinting’ Could Yield Long-Awaited Alzheimer’s Disease Diagnostic
Lawrence Berkeley National Laboratory

Some devastating diseases, like Alzheimer's and autoimmune conditions, are hard to diagnose correctly because doctors don’t yet know what genes or molecules to look for. But a new technique inspired by the Star Trek tricorder can spot disease without the clues, using infrared light and machine learning.



close
2.14757